Mr. Ronald A. Rader has been President of his own publishing/consulting company, the Biotechnology Information Institute, since late 1990. Mr. Rader has a B.S. (Microbiology), M.L.S. (Library Science), and 25+ years experience as a biotechnology and pharmaceutical information specialist, author and publisher. He is a world-class expert in biotechnology and pharmaceutical information, particularly competitive intelligence, market and technology assessments, and information resources development. [Resume]
Mr. Rader is best known as the author of Biopharmaceutical Products in the U.S. and European Markets, the only reference book concerning biopharmaceuticals (now in its 6th edition, 2 vol., 1602 pages).
For 15 years, from 1988-early 2003, he was author and publisher of the Antiviral Agents Bulletin, the only periodical specializing in antiviral/HIV drug and vaccine development. In 1994, he published the Federal Bio-Technology Transfer Directory, a 678-page book abstracting and indexing all federal, e.g., NIH, inventions and technology transfers in biotech/biomedical areas, further marketed as an online database until 2000.
From 1985-1990, Mr. Rader was Manager of Information Services, Porton International plc, providing information, competitive intelligence and market/technology analyses for what was then the world's largest privately-held biotechnology company. Prior to that he served as a biomedical/chemical information specialist/manager/analyst with companies including Gillette Medical Evaluation Labs., Gillette Co.; MITRE Corp.; Biospherics; Computer Sciences Corp. (CSC); Technical Resources Inc.; and Bio-Conversion Labs.
Recent industry periodical articles include:
- "Paucity of Biopharma Approvals Raises Alarm: Lower Numbers, Novelty and Economic Impact Indicate Problems," Genetic Engineering & Biotechnology News (GEN), March 15, 2008
- "What Is a Generic Biopharmaceutical? Biogeneric? Follow-On Protein? Biosimilar? Follow-On Biologic?" Part 1: Introduction and Basic Paradigms - BioProcess International, March 2007
- "What Is a Generic Biopharmaceutical? Biogeneric? Follow-On Protein? Biosimilar? Follow-On Biologic?" Part 2: Information, Nomenclature, Perceptions, and the Market/A> - BioProcess International, May 2007
- Biopharmaceutical Approvals Review - Genetic Engineering News, Aug. 1, 2006
-
What is a Biopharmaceutical, Part 1: (Bio)Technology-Based Definitions - BioExecutive, March 2005
- What is a Biopharmaceutical, Part 2: Company and Industry Definitions - BioExecutive, May 2005
Mr. Rader's main Web sites:
Earlier books, periodicals and studies authored by Mr. Rader include:
- BioINVENTION, a U.S. biotechnology patent abstract and news periodical; Editor, 1985-1990
- Federal Biotechnology Information Resources Directory; lead author/editor
- Federal Biotechnology Programs Directory; lead author/editor
- Survey of Compounds Which Have Been Tested for Carcinogenic Activity [Chemical Editor]
- "Analysis of U.S. Biotechnology Patents," issued annually, 1986-1988, by the Pharmaceutical Manufacturers Association (PMA, now PhRMA).
- Chemical Information Resources Directory, 673 pages
Further information: Resume
